oral semaglutide versus subcutaneous semaglutide Tablets vs Injection: Which Is Best? Effect of Continued Weekly Subcutaneous

(2024) 10:e27276

A GLP-1 receptor agonist is a type of medication that stimulates insulin release at high blood glucose levels and suppresses glucagon secretion under low blood glucose conditions

Their advertising carries a fine-print disclaimer which includes Results may vary based on individual and occasionally adds No results guaranteed. Under the Therapeutic Goods Act there should also be a clear disclaimer on the labels of products indicated for weight loss which says: When used in conjunction with a program of reduced intake of dietary calories and increased physical activity

It is the beginning of a formal regulatory process, and patients deserve to understand exactly what that difference means